November 5, 2024
Docket Number: FDA-2019-D-5743 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Office of Inspections and Investigations Office […]
November 5, 2024
SAN ANTONIO – Once-weekly tirzepatide (Zepbound) reduced the risk for progression from prediabetes to type 2 diabetes (T2D) by more than 90% at 3 years and […]
November 5, 2024
Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved biomarkers and cognitive outcomes in patients with dementia […]
November 5, 2024
TOPLINE: A survey of around 2000 German women up to 24 months postpartum finds that 66% say they are frustrated with their sex life, whereas only […]
November 5, 2024
TOPLINE: Nearly all patients reported receiving instructions to take levothyroxine (LT4) while fasting, but a third did not adhere to this. Approximately half of patients reported […]
November 5, 2024
Only 12% of the nurses providing patient care at hospitals and health clinics today are men. Although the percentage of nurses has increased — men made […]
November 5, 2024
TOPLINE: Greater exposure to per- and polyfluoroalkyl substances (PFAS) is linked to reduced kidney function in young adults, mediated by changes in the gut microbiome and […]
November 5, 2024
A growing body of research explores the link between stroke risk and regular consumption of coffee, tea, soda, and alcohol. This research roundup reviews the latest […]
November 5, 2024
A new vaccine using mRNA technology protected against first-time and relapsing Clostridioides difficile infection in animal models, according to a press release from the Perelman School […]